Investing

Kaspien Holdings Inc. (KSPN) experienced an increase in revenue for the second quarter of 2023, according to the company’s recently released quarterly report. In the thirteen weeks ending April 29, 2023, the company generated a total net revenue of $32.93 million, up from $31.79 million during the same period in 2022. This growth can be […]

Century Cobalt Corp Reports $1.06 Million in Notes Payable and Convertible Notes Payable Transactions for Q3 2022 Century Cobalt Corp, a mineral exploration and development company, has recently released its quarterly report highlighting key financial transactions and developments. The report provides valuable insights into the company’s financial position and performance for the three and nine

Financial Performance Overview Century Cobalt Corp., a Nevada corporation focused on the identification and exploration of mineral properties for discovering economical cobalt assets, recently reported its financial performance for the nine months ended August 31, 2022. The company recorded a net loss of $268,576 during this period, highlighting the challenges faced as it explores new

Century Cobalt Corp, a Nevada-based company, has reported its latest quarterly results, indicating a strong increase in the number of outstanding shares as of June 13, 2023. As of this date, the company has 104,361,576 outstanding shares of common stock, which represents an increase over previous periods. In this article, we will delve into the

American Bio Medica Corporation (ABMC), a leading diagnostic test kit manufacturer, has recently completed a major asset sale to Healgen, signifying a significant milestone in the company’s ongoing business strategy. Despite facing challenges related to supply chain delays and decreased product sales, ABMC remains focused on exploring strategic transactions and pursuing new business opportunities. Asset

Significant Improvements in Financial Position American Bio Medica Corporation (ABMC), a leading manufacturer of diagnostic test kits, has reported significant improvements in its financial position following the sale of nearly all of the company’s assets to Healgen Scientific Limited Liability Company (Healgen) in the first quarter of 2023. The asset sale, which included inventory, property,

Q1 2023 Financial Results American Bio Medica Corporation (ABMC), a leading diagnostic-technology firm, has reported its financial results for the first quarter ended March 31, 2023. The company’s unaudited interim condensed financial statements reflected a net income of $1,881,000 during the first quarter of 2023 compared to a net loss of $(379,000) during the first